INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 103 filers reported holding INHIBRX INC in Q3 2022. The put-call ratio across all filers is 34.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,300,098 | +51.3% | 70,850 | +114.0% | 0.00% | 0.0% |
Q2 2023 | $859,432 | -70.2% | 33,106 | -78.3% | 0.00% | -93.0% |
Q1 2023 | $2,884,317 | -43.4% | 152,852 | -26.2% | 0.04% | -53.8% |
Q4 2022 | $5,100,036 | +158.8% | 206,982 | +88.5% | 0.09% | +144.7% |
Q3 2022 | $1,971,000 | +155.0% | 109,816 | +61.2% | 0.04% | +81.0% |
Q2 2022 | $773,000 | -68.6% | 68,138 | -38.4% | 0.02% | -68.2% |
Q1 2022 | $2,463,000 | +1.6% | 110,532 | +99.0% | 0.07% | -12.0% |
Q4 2021 | $2,425,000 | – | 55,533 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 1,286,435 | $31,697,758 | 8.22% |
Perceptive Advisors | 3,313,783 | $81,651,613 | 2.29% |
RA Capital Management | 3,853,867 | $94,959,283 | 1.93% |
Soleus Capital Management, L.P. | 478,302 | $11,785,361 | 1.69% |
Sofinnova Investments, Inc. | 1,110,183 | $27,354,909 | 1.62% |
Birchview Capital, LP | 70,448 | $1,736 | 1.23% |
VIKING GLOBAL INVESTORS LP | 6,639,199 | $163,589,863 | 0.82% |
Meridian Wealth Advisors, LLC | 122,315 | $3,013,842 | 0.78% |
Gyon Technologies Capital Management, LP | 44,074 | $1,085,983 | 0.41% |
ArrowMark Colorado Holdings LLC | 1,139,337 | $28,073,264 | 0.34% |